Effect of GnRH antagonists treatment on gonadotrophin secretion, follicular development and inhibin A secretion in goats

The aim of this study was to determine, for goats, the effects of daily doses of GnRH antagonist on ovarian endocrine and follicular function. Ten does were given 45mg FGA intravaginal sponges and then five were treated with daily injections of 0.5mg of the GnRH antagonist Teverelix for 11 days from 2 days after the day of sponge insertion, while five does acted as controls. Pituitary activity was monitored by measuring plasma FSH and LH daily from 2 days before the first GnRH injection to Day 12. Follicular activity was determined by ultrasonographic monitoring and by assessing plasma inhibin A levels during the same period. In treated does, the FSH levels decreased linearly (0.8±0.1ng/ml to 0.5±0.1ng/ml, P<0.01) and remained lower than the mean concentration in control goats (0.8±0.1ng/ml, P<0.005). LH levels were also lower during the period of antagonist treatment (0.6±0.2ng/ml versus 0.4±0.1ng/ml, P<0.0005). During GnRH antagonist treatment, there was a significant decrease in the number of large follicles (≥6mm) from Day 3 of treatment (1.2±0.6, P<0.0001), with no large follicles from Day 9. The number of medium follicles (4-5mm in size) also decrease during the period of treatment (4.2±0.7 to 1.0±0.6, P<0.0001), leading to a significant decrease in inhibin A levels when compared to the control (143.7±31.3pg/ml versus 65.2±19.1pg/ml, P<0.00005). In contrast, the number of small follicles (2-3mm) increased in treated goats from Day 4 of treatment (9.6±2.9 to 20.2±6.3, P<0.005). Such data indicate that GnRH antagonist reduced plasma levels of FSH and LH with suppression of the growth of large dominant ovarian follicles and a two-fold increase in number of smaller follicles. The results confirm that GnRH antagonist treatment can be used in goats to control gonadotrophin secretion and ovarian follicle growth in superovulatory regimes. © 2003 Elsevier Inc. All rights reserved.

Saved in:
Bibliographic Details
Main Authors: González De Bulnes, Antonio, Santiago Moreno, Julián, Garcia-Garcia, R. M., Souza, C. J. H., López Sebastián, Antonio, McNeilly, A. S.
Format: artículo biblioteca
Language:English
Published: Elsevier 2004
Subjects:Follicle, GnRH analogues, Goat, Gonadotrophins, Superovulation,
Online Access:http://hdl.handle.net/20.500.12792/1917
http://hdl.handle.net/10261/292633
Tags: Add Tag
No Tags, Be the first to tag this record!
id dig-inia-es-10261-292633
record_format koha
spelling dig-inia-es-10261-2926332023-02-20T07:30:53Z Effect of GnRH antagonists treatment on gonadotrophin secretion, follicular development and inhibin A secretion in goats González De Bulnes, Antonio Santiago Moreno, Julián Garcia-Garcia, R. M. Souza, C. J. H. López Sebastián, Antonio McNeilly, A. S. Follicle GnRH analogues Goat Gonadotrophins Superovulation The aim of this study was to determine, for goats, the effects of daily doses of GnRH antagonist on ovarian endocrine and follicular function. Ten does were given 45mg FGA intravaginal sponges and then five were treated with daily injections of 0.5mg of the GnRH antagonist Teverelix for 11 days from 2 days after the day of sponge insertion, while five does acted as controls. Pituitary activity was monitored by measuring plasma FSH and LH daily from 2 days before the first GnRH injection to Day 12. Follicular activity was determined by ultrasonographic monitoring and by assessing plasma inhibin A levels during the same period. In treated does, the FSH levels decreased linearly (0.8±0.1ng/ml to 0.5±0.1ng/ml, P<0.01) and remained lower than the mean concentration in control goats (0.8±0.1ng/ml, P<0.005). LH levels were also lower during the period of antagonist treatment (0.6±0.2ng/ml versus 0.4±0.1ng/ml, P<0.0005). During GnRH antagonist treatment, there was a significant decrease in the number of large follicles (≥6mm) from Day 3 of treatment (1.2±0.6, P<0.0001), with no large follicles from Day 9. The number of medium follicles (4-5mm in size) also decrease during the period of treatment (4.2±0.7 to 1.0±0.6, P<0.0001), leading to a significant decrease in inhibin A levels when compared to the control (143.7±31.3pg/ml versus 65.2±19.1pg/ml, P<0.00005). In contrast, the number of small follicles (2-3mm) increased in treated goats from Day 4 of treatment (9.6±2.9 to 20.2±6.3, P<0.005). Such data indicate that GnRH antagonist reduced plasma levels of FSH and LH with suppression of the growth of large dominant ovarian follicles and a two-fold increase in number of smaller follicles. The results confirm that GnRH antagonist treatment can be used in goats to control gonadotrophin secretion and ovarian follicle growth in superovulatory regimes. © 2003 Elsevier Inc. All rights reserved. 2023-02-20T07:30:53Z 2023-02-20T07:30:53Z 2004 artículo Theriogenology 61(5): 977-985 (2004) 0093-691X http://hdl.handle.net/20.500.12792/1917 http://hdl.handle.net/10261/292633 10.1016/j.theriogenology.2003.07.003 1879-3231 en none Elsevier
institution INIA ES
collection DSpace
country España
countrycode ES
component Bibliográfico
access En linea
databasecode dig-inia-es
tag biblioteca
region Europa del Sur
libraryname Biblioteca del INIA España
language English
topic Follicle
GnRH analogues
Goat
Gonadotrophins
Superovulation
Follicle
GnRH analogues
Goat
Gonadotrophins
Superovulation
spellingShingle Follicle
GnRH analogues
Goat
Gonadotrophins
Superovulation
Follicle
GnRH analogues
Goat
Gonadotrophins
Superovulation
González De Bulnes, Antonio
Santiago Moreno, Julián
Garcia-Garcia, R. M.
Souza, C. J. H.
López Sebastián, Antonio
McNeilly, A. S.
Effect of GnRH antagonists treatment on gonadotrophin secretion, follicular development and inhibin A secretion in goats
description The aim of this study was to determine, for goats, the effects of daily doses of GnRH antagonist on ovarian endocrine and follicular function. Ten does were given 45mg FGA intravaginal sponges and then five were treated with daily injections of 0.5mg of the GnRH antagonist Teverelix for 11 days from 2 days after the day of sponge insertion, while five does acted as controls. Pituitary activity was monitored by measuring plasma FSH and LH daily from 2 days before the first GnRH injection to Day 12. Follicular activity was determined by ultrasonographic monitoring and by assessing plasma inhibin A levels during the same period. In treated does, the FSH levels decreased linearly (0.8±0.1ng/ml to 0.5±0.1ng/ml, P<0.01) and remained lower than the mean concentration in control goats (0.8±0.1ng/ml, P<0.005). LH levels were also lower during the period of antagonist treatment (0.6±0.2ng/ml versus 0.4±0.1ng/ml, P<0.0005). During GnRH antagonist treatment, there was a significant decrease in the number of large follicles (≥6mm) from Day 3 of treatment (1.2±0.6, P<0.0001), with no large follicles from Day 9. The number of medium follicles (4-5mm in size) also decrease during the period of treatment (4.2±0.7 to 1.0±0.6, P<0.0001), leading to a significant decrease in inhibin A levels when compared to the control (143.7±31.3pg/ml versus 65.2±19.1pg/ml, P<0.00005). In contrast, the number of small follicles (2-3mm) increased in treated goats from Day 4 of treatment (9.6±2.9 to 20.2±6.3, P<0.005). Such data indicate that GnRH antagonist reduced plasma levels of FSH and LH with suppression of the growth of large dominant ovarian follicles and a two-fold increase in number of smaller follicles. The results confirm that GnRH antagonist treatment can be used in goats to control gonadotrophin secretion and ovarian follicle growth in superovulatory regimes. © 2003 Elsevier Inc. All rights reserved.
format artículo
topic_facet Follicle
GnRH analogues
Goat
Gonadotrophins
Superovulation
author González De Bulnes, Antonio
Santiago Moreno, Julián
Garcia-Garcia, R. M.
Souza, C. J. H.
López Sebastián, Antonio
McNeilly, A. S.
author_facet González De Bulnes, Antonio
Santiago Moreno, Julián
Garcia-Garcia, R. M.
Souza, C. J. H.
López Sebastián, Antonio
McNeilly, A. S.
author_sort González De Bulnes, Antonio
title Effect of GnRH antagonists treatment on gonadotrophin secretion, follicular development and inhibin A secretion in goats
title_short Effect of GnRH antagonists treatment on gonadotrophin secretion, follicular development and inhibin A secretion in goats
title_full Effect of GnRH antagonists treatment on gonadotrophin secretion, follicular development and inhibin A secretion in goats
title_fullStr Effect of GnRH antagonists treatment on gonadotrophin secretion, follicular development and inhibin A secretion in goats
title_full_unstemmed Effect of GnRH antagonists treatment on gonadotrophin secretion, follicular development and inhibin A secretion in goats
title_sort effect of gnrh antagonists treatment on gonadotrophin secretion, follicular development and inhibin a secretion in goats
publisher Elsevier
publishDate 2004
url http://hdl.handle.net/20.500.12792/1917
http://hdl.handle.net/10261/292633
work_keys_str_mv AT gonzalezdebulnesantonio effectofgnrhantagoniststreatmentongonadotrophinsecretionfolliculardevelopmentandinhibinasecretioningoats
AT santiagomorenojulian effectofgnrhantagoniststreatmentongonadotrophinsecretionfolliculardevelopmentandinhibinasecretioningoats
AT garciagarciarm effectofgnrhantagoniststreatmentongonadotrophinsecretionfolliculardevelopmentandinhibinasecretioningoats
AT souzacjh effectofgnrhantagoniststreatmentongonadotrophinsecretionfolliculardevelopmentandinhibinasecretioningoats
AT lopezsebastianantonio effectofgnrhantagoniststreatmentongonadotrophinsecretionfolliculardevelopmentandinhibinasecretioningoats
AT mcneillyas effectofgnrhantagoniststreatmentongonadotrophinsecretionfolliculardevelopmentandinhibinasecretioningoats
_version_ 1767603371947065344